Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The Journal of Experimental Biology
|
June 30, 2009
Hyperunstable matrix proteins in the byssus of Mytilus galloprovincialis
Jason Sagert, J Herbert Waite
The Journal of Biological Chemistry
|
July 9, 2009
Glycosylated hydroxytryptophan in a mussel adhesive protein from Perna viridis
Hua Zhao, Jason Sagert, Dong Soo Hwang, et al.
Biomacromolecules
|
July 13, 2004
Giant bent-core mesogens in the thread forming process of marine mussels
Tue Hassenkam, Thomas Gutsmann, Paul Hansma, et al.
Food Microbiology
|
April 2, 2013
Antimicrobial resistance and co-selection phenomenon in Listeria spp. recovered from food and food production environments
Jovana Kovacevic, Jason Sagert, Anna Wozniak, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 29, 2019
Quantitative Systems Pharmacology Model of a Masked, Tumor-Activated Antibody
Mark Stroh, Jason Sagert, John M Burke, et al.
Biorxiv : the Preprint Server for Biology
|
May 7, 2026
Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors
Mingyu Huo, Dan Li, Nan Li, et al.
JCI Insight
|
October 3, 2023
TSC2 S1365A mutation potently regulates CD8+ T cell function and differentiation and improves adoptive cellular cancer therapy
Chirag H Patel, Yi Dong, Navid Koleini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2015
PKCα Attenuates Jagged-1-Mediated Notch Signaling in ErbB-2-Positive Breast Cancer to Reverse Trastuzumab Resistance
Kinnari Pandya, Debra Wyatt, Brian Gallagher, et al.
Cancer Immunology Research
|
October 12, 2021
Conditional PD-1/PD-L1 Probody Therapeutics Induce Comparable Antitumor Immunity but Reduced Systemic Toxicity Compared with Traditional Anti-PD-1/PD-L1 Agents
Hikmat H Assi, Chihunt Wong, Kimberly A Tipton, et al.
Molecular Cancer Therapeutics
|
June 6, 2022
Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody-Drug Conjugate
Shweta Singh, Laura Serwer, Amy DuPage, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The Journal of Experimental Biology
|
June 30, 2009
Hyperunstable matrix proteins in the byssus of Mytilus galloprovincialis
Jason Sagert, J Herbert Waite
The Journal of Biological Chemistry
|
July 9, 2009
Glycosylated hydroxytryptophan in a mussel adhesive protein from Perna viridis
Hua Zhao, Jason Sagert, Dong Soo Hwang, et al.
Biomacromolecules
|
July 13, 2004
Giant bent-core mesogens in the thread forming process of marine mussels
Tue Hassenkam, Thomas Gutsmann, Paul Hansma, et al.
Food Microbiology
|
April 2, 2013
Antimicrobial resistance and co-selection phenomenon in Listeria spp. recovered from food and food production environments
Jovana Kovacevic, Jason Sagert, Anna Wozniak, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 29, 2019
Quantitative Systems Pharmacology Model of a Masked, Tumor-Activated Antibody
Mark Stroh, Jason Sagert, John M Burke, et al.
Biorxiv : the Preprint Server for Biology
|
May 7, 2026
Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors
Mingyu Huo, Dan Li, Nan Li, et al.
JCI Insight
|
October 3, 2023
TSC2 S1365A mutation potently regulates CD8+ T cell function and differentiation and improves adoptive cellular cancer therapy
Chirag H Patel, Yi Dong, Navid Koleini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2015
PKCα Attenuates Jagged-1-Mediated Notch Signaling in ErbB-2-Positive Breast Cancer to Reverse Trastuzumab Resistance
Kinnari Pandya, Debra Wyatt, Brian Gallagher, et al.
Cancer Immunology Research
|
October 12, 2021
Conditional PD-1/PD-L1 Probody Therapeutics Induce Comparable Antitumor Immunity but Reduced Systemic Toxicity Compared with Traditional Anti-PD-1/PD-L1 Agents
Hikmat H Assi, Chihunt Wong, Kimberly A Tipton, et al.
Molecular Cancer Therapeutics
|
June 6, 2022
Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody-Drug Conjugate
Shweta Singh, Laura Serwer, Amy DuPage, et al.
Page
of 1